Acinetobacter baumannii (AB) has emerged
as a significant nosocomial pathogen in hospitalized
patients worldwide. Acinetobacter baumannii is a
non-fermenting, gram-negative coccobacillus, which
lives in soil and water, survives for a long period on dry
surfaces, and can probably be transmitted via dust and
fomites. Most clinical isolates represent colonization
rather than infection, but serious and sometimes fatal
infections occur in compromised patients, including septicemia, endocarditis, meningitis, and pneumonia(1,2